The 2023 antiinfective medicine sales show Italy leading among the listed countries, despite a significant 4.51% year-on-year decline. Croatia, however, saw a substantial increase of 21.52%, marking it as a standout performer. While most countries such as New Zealand and Sweden experienced declines, smaller markets like Iceland and Luxembourg achieved notable growth of 6.72% and 8.75%, respectively. Long-term growth trends can be seen in countries like Norway and Slovakia, which show annual positive changes. In contrast, the primary markets indicate a contraction.
Trends to watch for in 2024 and beyond include:
- Continued robust growth in emerging markets such as Croatia.
- Potential recovery in established markets like Italy and Spain.
- Impact of healthcare policy changes and innovations in antiinfective treatments on sales dynamics.
Top countries in Antiinfective Medicine Sales Share by Country (Million US Dollars)
| # | 10 Countries | Percent | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Italy | 23.9 | 2023 | -0.19% | -4.51% | View data |
| 2 | 2 Spain | 17.1 | 2023 | +6.74% | -1.93% | View data |
| 3 | 3 Croatia | 16.78 | 2023 | +18.25% | +21.52% | View data |
| 4 | 4 Australia | 11.37 | 2023 | +6.05% | -0.58% | View data |
| 5 | 5 Mexico | 10.29 | 2023 | +2.84% | -0.35% | View data |
| 6 | 6 Belgium | 6.39 | 2023 | +2.46% | -0.61% | View data |
| 7 | 7 Sweden | 3.42 | 2023 | +11.79% | -5.59% | View data |
| 8 | 8 Finland | 2.66 | 2023 | +2.36% | +0.84% | View data |
| 9 | 9 Austria | 2.63 | 2023 | +2.72% | +0.63% | View data |
| 10 | 10 Norway | 2.56 | 2023 | -19.77% | +1.63% | View data |
